![Pierre Sayad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Sayad
Technik-/Wissenschafts-/F&E-Leiter bei
FENNEC PHARMACEUTICALS INC.
Vermögen: 208 679 $ am 31.05.2026
Profil
Pierre S.
Sayad is currently Chief Medical Officer at Fennec Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Sayad was Senior Vice President-Global Medical Affairs at International Myeloma Foundation, Vice President-Global Medical & Scientific Affairs at Karyopharm Therapeutics, Inc., and Chief Operating & Medical Officer at Zephyr Group, Inc. Education includes graduate studies at Loma Linda University and undergraduate studies at San Jose State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 21 015 ( 0,06 % ) | 208 679 $ | 31.05.2026 |
Aktive Positionen von Pierre Sayad
| Unternehmen | Position | Beginn |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.10.2024 |
Ehemalige bekannte Positionen von Pierre Sayad
| Unternehmen | Position | Ende |
|---|---|---|
International Myeloma Foundation
 International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Corporate Officer/Principal | - |
| KARYOPHARM THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Pierre Sayad
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
International Myeloma Foundation
International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Commercial Services |
Loma Linda University
 Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
